BFO
Biltmore Family Office’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Hold |
8,828
| – | – | 0.19% | 81 |
|
2025
Q1 | $1.13M | Hold |
8,828
| – | – | 0.19% | 81 |
|
2024
Q4 | $1.17M | Sell |
8,828
-212
| -2% | -$28K | 0.2% | 78 |
|
2024
Q3 | $1.32M | Sell |
9,040
-125
| -1% | -$18.2K | 0.23% | 77 |
|
2024
Q2 | $1.26M | Hold |
9,165
| – | – | 0.23% | 70 |
|
2024
Q1 | $1.26M | Sell |
9,165
-867
| -9% | -$119K | 0.25% | 69 |
|
2023
Q4 | $1.36M | Buy |
10,032
+9,507
| +1,811% | +$1.29M | 0.28% | 61 |
|
2023
Q3 | $64.3K | Hold |
525
| – | – | 0.01% | 196 |
|
2023
Q2 | $66.7K | Hold |
525
| – | – | 0.01% | 191 |
|
2023
Q1 | $67.8K | Hold |
525
| – | – | 0.01% | 232 |
|
2022
Q4 | $68.9K | Hold |
525
| – | – | 0.01% | 221 |
|
2022
Q3 | $61K | Hold |
525
| – | – | 0.01% | 176 |
|
2022
Q2 | $62K | Hold |
525
| – | – | 0.02% | 176 |
|
2022
Q1 | $68K | Hold |
525
| – | – | 0.01% | 184 |
|
2021
Q4 | $80K | Hold |
525
| – | – | 0.02% | 199 |
|
2021
Q3 | $85K | Hold |
525
| – | – | 0.02% | 177 |
|
2021
Q2 | $86K | Hold |
525
| – | – | 0.02% | 163 |
|
2021
Q1 | $79K | Hold |
525
| – | – | 0.02% | 156 |
|
2020
Q4 | $80K | Hold |
525
| – | – | 0.02% | 157 |
|
2020
Q3 | $71K | Hold |
525
| – | – | 0.04% | 140 |
|
2020
Q2 | $72K | Hold |
525
| – | – | 0.04% | 150 |
|
2020
Q1 | $57K | Sell |
525
-150
| -22% | -$16.3K | 0.04% | 145 |
|
2019
Q4 | $81K | Sell |
675
-750
| -53% | -$90K | 0.03% | 172 |
|
2019
Q3 | $142K | Hold |
1,425
| – | – | 0.06% | 147 |
|
2019
Q2 | $155K | Buy |
+1,425
| New | +$155K | 0.08% | 135 |
|